CRA analyzed market definition in antitrust litigation concerning a product in the non-opioid pain category. In defining the relevant antitrust market, our work accounted for indicators of competition among branded pharmaceutical products, including market positioning, factors driving physician choice, development of new approved indications, and competition for formulary listing.
Antitrust in the Middle East: New competition laws, and time for more economics?
In the Middle East, competition law is being increasingly enforced and new laws introduced. However, little has been said about how, if at all the role...